Bibliografía
1. Nielsen OH, Rejnmark L, Moss AC. Role of vitamin D in the natural history of inflammatory bowel disease. J Crohns Colitis 2018 (en imprenta)
2. White J. Vitamin D deficiency and the pathogenesis of Crohn´s disease. J Steroid Biochem Mol Biol 2018;175:23-28.
3. Mouli VP, Ananthakrishnan AN. Review article: vitamin D and inflammatory bowel diseases. Aliment Pharmacol Ther 2014;39:125-36.
4. Del Pinto R, Pietropaoli D, Chandar AK et al. Association between inflammatory bowel disease and vitamin D deficiency: a systematic review and meta-analysis. Inflamm Bowel Dis 2015; 21: 2708-17.
5. Sánchez-Cano D, Ruiz-Villaverde R, Callejas Rubio, JL et al. Vitamin D deficiency and bone mineral density in Crohn´s disease. Med Clin 2011;137:62-65.
6. Sadeghian M, Saneei P, Siassi F, et al. Vitamin D status in relation to Crohn´s disease:Meta-analysis of observational studies. Nutrition 2016;32:505-14.
7. Frigstad SO, Hoivik M, Jahnsen J et al. Vitamin D deficiency in inflammatory bowel disease:prevalence and predictors in a Norwegian outpatient population. Scand J Gastroenterol 2017; 52:100-106.
8. Raferty T, Merrick M, Healy M, et al. Vitamin D status is associated with intestinal inflammation as measured by fecal calprotectin in Crohn´s disease in clinical remission. Dig Dis Sci 2015; 60:2427-35.
9. Garg M, Rosella O, Lubel JS, et al. Association of circulating vitamin D concentrations with intestinal but not systemic inflammation in inflammatory bowel disease. Inflamm Bowel Dis 2013;19:2634-43.
10. Hlavaty T, Krajcovicoca A, Koller T, et al. Higher vitamin D serum concentrations increases health related quality of life in patients with inflammatory bowel diseases. Word J Gastroenterol 2014;20:15787-96.
11. Torki M, Gholamrezaei A, Mirbagher L, et al. Vitamin D deficiency associated with disease activity inpatients with inflmammatory bowel diseases. Dig Dis Sci 2015; 60:3085-91.
12. Mikocka-Walus A, Knowles SR, Keefer L, et al. Controversies revisited: a systematic review of the comorbidity of depression and anxiety with inflammatory bowel diseases. Inflamm Bowel Dis 2016; 22:752-62.
13. Cuomo A, Giordano N, Goracci A, et al. Depression and vitamin D deficiency: causality, assessment, and clinical implications. Neuropsychiatry 2017; 606-614.
14. Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl; 1989; 170: 2-6.
15. Silverberg MS, Satsangi J, Ahmad T, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroentrol 2005;19 Suppl A: 5-36A.
16. Holick MF, Binkley HA, Heike A, et al. Evaluation, treatment and prevention of vitamin D deficiency:an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab; 1911-30.
17. Colombel JF, Sandborn WJ, Rutgeerts P, et al. Adalimumab for maintenance of clinical response and remission in patients with Crohn’s
disease: the CHARM trial. Gastroenterology; 2007:132:52–65.
18. Vázquez-Morón JM, Pallarés-Manrique H, Machancoses FH et al. Accurate cut-offs for predicting endoscopic activity and mucosal healing in Crohn´s disease with fecal calprotectin. Rev Esp Enferm Dig; 2017; 109:130-136.
19. Utilsky A, Ananthakrishnan AN, Naik A, et al. Vitamin D deficiency in patients with inflammatory bowel disease: association with disease activity andquality of life. J Parenter Enteral Nutr 2011;35:308-316.
20. Blanck S, Aberra F. Vitamin D deficiency is associated with ulcerative colitis disease activity. Dig Dis Sci 2013;58:1698-702.
21. Dias de Castro F, Magalhaes J, Boal Carvalho P, et al. Lower levels of vitamin D correlate with clinical disease activity and quality of life in inflammatory bowel disease. Arq Gastroenterol 2015;52: 260-265.
22. Schäffler H, Schmidt M, Huth A, et al. Clinical factors are associated with vitamin D levels in IBD patients: a retrospective analysis. J Dig Dis 2018; 19: 24-32.
23. Hassan V, Hassan S, Seyed-Javad P, et al. Association between serum 25 (oh) vitamin D concentrations and inflammatory bowel diseases (IBDs) activity. Med J Malaysia 2013; 68:34-38
24. Jorgensen SP, Hvas CL, Agnholt J, et al. Active Crohn´s disease is associated with low vitamin D levels. J Crohns Colitis 2013; e407-413.
25. Dolatshahi S, Pishgar E, Jamali R. Does serum 25 hidroxy vitamin D level predict disease activity in ulcerative colitis patients? Acta Clin Belg 2016; 71: 46-50.
26. Ham M, Longhi MS, Lahiff C, et al. Vitamin D levels in adults with Crohn´s disease are responsive to disease activity and treatment. Inflamm Bowel Dis 2014;20:856-60.
27. Schoepfer AM, Berlinger C, Strautmann A, et al. Fecal calprotectin correlates more closely with the Simple Endoscopic Score for Crohn´s disease (SES-CD) than PCR, blood leukocytes, and the CDAI. Am J Gastroenterol 2010; 105:162-9.
28. Kini GP, Young B, Herbison P, et al. Does seasonal level of serum 25-OH correlate with the activity of Croh´s disease? N Z Med J 2014;127:51-59.
29. Leichtmann GA, Bengoa JM, Bolt MJ, et al. Intestinal absorption of cholecalciferol and 25-hydroxycholecalciferol in patients with both Crohn’s disease and intestinal resection. Am J Clin Nutr 1991;51: 548-552
30. Tajika M, Matsuura A, Nakamura T, et al. Risk factors for vitamin D deficiency in patients with Crohn’s disease. J Gastroenterol 2004; 39:527-33.
31. Zullow S, Jambaulikar G, Rustgi A, et al. Risk factors for deficiency and impact repletion in a tertiary care inflammatory bowel disease population. Dig Dis Sci 2017;62:2072-78
32. Kabbani TA, Koutroubakis IE, Schoen RE, et al. Association of vitamin D level with clinical status in inflammatory bowel disease: a 5-year longitudinal study. Am J Gastroenterol 2016;111:712-9.
33. Gilman J, Shanahan F, Cashman KD. Determinants of vitamin D status in adult Crohn’s disease patients, with particular emphasis on supplemental vitamin D use. Eur J Clin Nutr. 2006;60: 889–896.
34. de Bruyn JR, van Heeckeren R, Ponsioen CY, et al. Vitamin D deficiency in Crohn’s disease and healthy controls: a prospective case-control study in the Netherlands. J Crohns Colitis 2014;8: 1267–1273.
35. Pallav K, Riche D, May WL, et al. Predictors of vitamin D deficiency in inflammatory bowel disease and health: a Mississippi perspective. World J Gastroenterol 2017; 28:638-645.
36. Suibhne TN, Cox G, Healy M, et al. Vitamin D deficiency in Crohn’s disease: prevalence, risk factors and supplement use in an outpatient setting. J Crohns Colitis 2012; 6:182–188.
37. Zator ZA, Cantu SM, Konijeti GG, et al. Pretreatment 25-hydroxivitamin D levels and durability of anti-tumour necrosis factor-alpha therapy in inflammatory bowel diseases. J Parenter Enteral Nutr 2014; 38:385-91.
38. Winter RW, Collins E, Cao B, et al. Higher 25-hydroxyvitamin D levels are associated with greater odds of remission with anti-tumour necrosis factor-alpha medications among patients with inflammatory bowel diseases. Aliment Pharmacol Ther 2017;45:653-659.
39. Malmstroem S, Rejnmark L, Imboden JB, et al. Current assays to determine free 25-hidroxyvitamin D in serum. J AOAC Int 2017; 5:1323-1327.